Article
Alzheimer's 2030: From Precision Genomics to Artificial Intelligence.
Genes - 12 Feb 2026
D'Argenio Valeria, Tomaiuolo Rossella, Bargeri Silvia, Sancesario Giulia
Abstract excerpt
Alzheimer's disease (AD) represents a critical global health challenge, with its prevalence and associated costs expected to double significantly by 2030 and 2050. While lifestyle interventions are crucial, sporadic late-onset AD has a substantial genetic component (40-80% heritability), though known variants limit the scope of traditional precision medicine. Crucially, sex and gender are significant risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
